Tekniskt fel med storägares aktier bakom avbrutna budet på Integrum

Medtech Magazine reports that medical technology company Osteocentric has officially withdrawn its acquisition offer for Integrum. The company cited insufficient shareholder acceptance as the primary reason. Osteocentric's offer stipulated a 90% acceptance rate, but it ultimately secured only approximately 69.4%. Integrum has disputed this conclusion in a subsequent statement. The company asserts that the acceptance condition was not met due to a technical issue that prevented founder and major shareholder Rickard Brånemark, who holds approximately 28% of Integrum's shares, from tendering his stake. Brånemark had reportedly made an irrevocable commitment to accept the offer. This development halts the proposed acquisition and requires Integrum to reassess its future strategy.